|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.04 CNY | +1.72% |
|
-2.90% | -4.74% |
| 05-20 | Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Board Appointments | CI |
| 05-20 | Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2023 | CI |
Jiangxi Synergy Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 587.41 million compared to CNY 435.42 million a year ago. Net income was CNY 80.37 million compared to CNY 70.05 million a year ago.
Basic earnings per share from continuing operations was CNY 0.2603 compared to CNY 0.2264 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.74% | 582M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. 
